Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19 (ACTT-2)
Evidence Based Medicine presented by InpharmD™ · InpharmD™
January 4, 20216m 37s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A randomized, multicenter, adaptive, double-blind, placebo-controlled trial to evaluate whether the combination of baricitinib plus remdesivir was superior to remdesivir alone.